TABLE 2.
Database name | Database type | Omics-types | Raw-data inspection platform | Clinical data availability | Analysis feature | Multi-cohort/dataset comparison | Multi-omics integration feature | Visualization feature |
TCGA | Cancer-specific | Genomics | GDC portal | + | + | + | + | + |
Epigenomics Transcriptomics | ||||||||
Proteomics | ||||||||
ICGC | Cancer-specific | Genomics Transcriptomics | ICGC data portal | + | + | + | + | + |
COSMIC | Cancer-specific | Genomics | Available | + | + | + | – | + |
TPA* | Cancer-specific | TMA-based IHC* | Available | + | + | + | – | + |
GEO | Generalized# | Transcriptomics | Available | + | + | – | – | + |
PRIDE | Generalized# | Proteomics | Available | – | – | – | – | – |
TCGA, The Cancer Genome Atlas; ICGC, International Cancer Genome Consortium; COSMIC, Catalogue Of Somatic Mutations In Cancer; TPA, The Pathology Atlas; GEO, Gene Expression Omnibus; PRIDE, PRoteomics IDEntifications. *Tissue-microarray based immunohistochemistry; #These databases integrate data from healthy subjects and cancer patients; + indicates availability; – indicates unavailability.